Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

http://theroc.us/researchlibrary/Effects%20of%20the%20cannabinoid-1%20receptor%20blocker%20rimonabant%20on%20weight%20reduction%20and%20cardiovascular%20risk%20factors%20in%20overweight%20patients-%201-year%20experience%20from%20the%20RIO-Europe%20study.pdf